Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Strong Proof-of-Concept for cross-strain protective flu cVLP vaccine further strengthens confidence in Coronavirus vaccine

Hørsholm, Denmark, July 17, 2020 – ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) announces that AdaptVac has announced publication of a paper in the journal Vaccines, where its broadly protective Flu cVLP vaccine induced a more potent, long-lasting immune response and was able to protect mice against both homologous and heterologous H1N1 influenza challenge, even after a single dose.Dr. Wian de Jongh, CSO in ExpreS[2]ion and CEO of AdaptVac comments: “These very promising results demonstrate the potential of the cVLP platform to be protective even after a single vaccine dose. In light of

Altech becomes Obducat’s new distributor in Japan

OBDUCAT AB (publ), a leading supplier of lithography processing solutions and nanoimprint lithography (NIL) tools, recently contracted the Japanese distributor Altech Co, Ltd. to represent Obducat’s entire product portfolio in Japan. This agreement came to effect on the 1[st] of July 2020.Altech was founded in 1976 and is well-established in the Japanese market. Obducat and Altech has a longstanding relationship since many years.  ” Altech’s sales organization is highly skilled with a well-established network within relevant market application areas such as biotechnical and optical

Interim Report 1 April – 30 June 2020

[Pl Ryfors CEO Episurf Medical] “Despite this very challenging business climate, Episurf has taken some significant and critical steps during the quarter. The number of orders for Episealer® implants exceeded the corresponding quarter previous year. This was an exceptionally strong achievement in what are the most challenging market conditions in living memory, patient recruitment in the pivotal clinical trial in the US was initiated, the first surgeries since the CE-clearance of our ankle implant Episealer® Talus were performed, the first surgery in Asia was planned, and the results

Polygiene and TK-Domashniy Tekstyl sign distributor agreement – starting with a million facemasks and 100 000 protection suits

Polygiene and TK-Domashniy Tekstyl, a home textile company in the Ukraine, has signed an exclusive distributors agreement for the Ukrainian market.TK-Domashniy Tekstyl is a major player in home textiles, working on all levels in their field, from raw materials, lego production and over 5000 consumer articles, exporting to many countries beyond the Ukraine. They are also the leading supplier of textile products to the Ukrainian government and the only company with production of medical suits in Ukraine. It is here the partnership starts, with an initial batch of 1 million ViralOff treated

Interim Report January-June 2020

“While covid-19 has had a severe impact on people and the global economy, it has also given us insights to build upon. Furthermore, the pandemic has accelerated the already strong trends of digitalization, automation and integration of sustainability into business operations. We will support our companies in capturing these opportunities.”Johan Forssell, President & CEO of InvestorHighlights during the second quarter · Adjusted net asset value (NAV) amounted to SEK 490,950m (SEK 641 per share) on June 30, 2020, an increase of SEK 59,920m, or 14 percent, with dividend added back,

Half Year Report January – June 2020

Q2 sales and profit growth driven by ZYN in the US · In local currencies, sales increased by 11 percent for the second quarter. Reported sales increased by 11 percent to 4,133 MSEK (3,719). · In local currencies, operating profit from product segments[1)] increased by 19 percent for the second quarter. Reported operating profit from product segments increased by 17 percent to 1,704 MSEK (1,456). · Operating profit amounted to 1,666 MSEK (1,434) for the second quarter. · Profit after tax amounted to 1,227 MSEK (1,080) for the second quarter. · Earnings per share increased by

Increased service life in Arise’s wind farms

Following an in-depth technical analysis performed by a third party, the expected economic lifetime for the company’s own wind farms will increase from an average of 25 years to approximately 30 years. This is expected to result in about a MSEK 9 decrease in depreciation annually, starting in August 2020. ”I am delighted that our wind farms are expected to have a 30-year service life following a proper examination. The remaining service life thereby increases from just over 15 to just over 20 years, strengthening the long-term value of our wind farms.”, says Daniel Johansson, CEO.

Interim Report 1 January – 30 June 2020

” All time high quarter with strong results!” APRIL – 30 JUNE 2020 (3 MONTHS) · Net sales increased by 48 percent to SEK 1,248 million (844), of which organic growth amounted to 39 percent and acquired growth amounted to 13 percent. · EBITA increased by 167 percent to SEK 181 million (68), corresponding to an EBITA-margin of 14.5 percent (8.1). · Profit after tax increased by 284 percent to SEK 120 million (31). · Earnings per share amounted to SEK 1.07 (0.28). · Cash flow from operating activities amounted to SEK 128 million (65). JANUARY – 30 JUNE 2020 (6 MONTHS)

BONESUPPORT HOLDING AB (publ) – Publishes Q2 2020 Interim report

Lund, Sweden, 08:00 am CET, July 17, 2020 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, today publishes the interim report for the second quarter 2020. STRONG SALES GROWTH IN THE US ”I am proud of the strategic progress we have achieved during the quarter and the organization’s ability to adapt the business to the current circumstances.” Emil Billbäck, CEO. APRIL - JUNE 2020 · Net sales decreased by 3 percent and amounted to SEK 36.2 million (37.3). · The North America (NA) segment reported a sales increase of 46

Interim Report January-June 2020

Attack is the best form of defenseSecond quarter · Net sales amounted to MSEK 85.0 (70.0), rendering a net sales growth of 21% (14%). Organic net sales growth was 17% (14%) · Recurring revenue amounted to MSEK 48.5 (41.3) · The quarter was impacted by one-off items affecting comparison amounting to MSEK 0.0 (0.6), The comparative figure is attributable to acquisitions · Adjusted EBITA amounted to MSEK 21.8 (13.8) which corresponds to an adjusted EBITA margin of 26% (20%) · Net income amounted to MSEK 13.3 (7.4) · Earnings per share, before dilution, amounted to SEK 1.00 (

Eurobattery Minerals’ rights issue subscribed to 209 per cent, the company will receive SEK 47.3 million

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL, BE SUBJECT TO LEGAL RESTRICTIONS OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES Eurobattery Minerals AB (NGM Nordic SME: "BAT"; "the Company") has completed the rights issue of units with subscription period from 29 June to 14 July 2020 (the "Rights issue"). The Rights issue has been

Interim report 1 January – 30 June 2020

Second quarter (1 April – 30 June 2020) · Net sales for the quarter amounted to MSEK 30 (67). · Operating profit/loss before depreciation and amortisation (EBITDA) totalled MSEK 6 (9). · Operating profit/loss (EBIT) was MSEK -12 (-10). · Profit/loss before tax amounted to MSEK -28 (-30). · Profit/loss after tax totalled MSEK -27 (-29), corresponding to SEK -0.80 (-0.87) per share before and after dilution. · Operating cash flow was MSEK 6 (98). · Production from Own wind power operations was 75 GWh (73). The increase was due to stronger wind conditions than in the

Biotage AB (publ) Interim report January - June 2020

Challenging quarter and improved cash flowApril - June · Net sales amounted to 254.2 MSEK (282.1), a decrease by 9.9 percent and organically[*] a decrease by 12.1%. · Operating profit amounted to 24.5 MSEK (56.1). · Result after tax amounted to 32.2[1)] MSEK (54.2). · Earnings per share was 0,49[1) ]SEK (0.83) before and after dilution. · The cash flow from operating activities increased by 13.9 MSEK to 57.0 MSEK (43.1). · Net cash* at June 30 amounted to 32.1 MSEK (net debt 69.2). · Cash and cash equivalents amounted to 260.7 MSEK (185.9). · Liabilities to credit

Gunnebo Interim Report, April-June 2020: innovative launches in a quarter burdened by Covid-19 pandemic

Second quarter 2020 · Order intake amounted to MSEK 948 (1,362), a decrease of 31% · Order book amounted to MSEK 1,426 (1,393), an increase of 2% · Net sales amounted to MSEK 952 (1,368), a decrease of 30% · EBITA amounted to MSEK 0 (73) and the EBITA margin was 0.0% (5.3) · Adjusted EBIT amounted to MSEK –3 (71) and the adjusted EBIT margin was –0.3% (5.2) · Net profit for the period amounted to MSEK –71 (24) · Earnings per share amounted to SEK –0.75 (0.32) · Free cash flow amounted to MSEK 92 (–32), and free cash flow per share amounted to SEK 0.97 (–0.42)

INVITATION: Finnair Q2 2020 result – Press conference and analyst webcasts

Finnair will hold a Q2 financial result press conference (in Finnish) on 24 July 2020 at 11:00 a.m. via live webcast: https://finnairgroup.videosync.fi/2020-0724-press An English-language telephone conference and webcast will begin at 1:00 p.m. Finnish time. The conference may be attended by dialling your local access number +358 (0)9 8171 0310 (Finland), 08 5664 2651 (Sweden), 033 3300 0804 (UK) or +44 (0)33 3300 0804 (all other countries). The confirmation code is 16413218#. We kindly suggest to call in 5 minutes before the conference begins. To join the live webcast, please register

Munters January-June 2020 interim report – ”Next step in the strategy implementation”

April-June 2020 · Order intake increased 2%, currency adjusted 1%. · Net sales declined by -6%, currency adjusted -6%, mainly due to a weak development in the industrial segment and in Mist Elimination within business area AirTech. This was partly offset by increasing net sales in business area FoodTech driven by a strong growth in China. · The adjusted EBITA-margin was stronger at 14.7% (13.9), mainly because of a higher margin in business area FoodTech. · Leverage (net debt/adj. EBITDA, LTM*) decreased to 2.7x from 3.1x end of March 2020. · Next step has been decided for

Interim report January–June 2020

Resilient performance in uncertain timesKey highlights · Continued sales volume increase · Relatively limited impact from Covid-19 · KM7 ramp-up progress as planned · Earnings continued to be affected by lower market prices · On track to deliver our cost- and efficiency program Quarterly data · Net sales declined by 2% to SEK 6 156 million (6 293) · Sales volumes grew by 4% compared to second quarter last year · Adjusted EBITDA* was SEK 774 million (539) · Operating profit was SEK 245 million (194) · Net profit was SEK 202 million (182) · Earnings per

Electrolux Q2 interim report 2020: Navigating through challenging market with reinforced strategy

The comments and figures in this report refer to continuing operations unless otherwise stated Highlights of the second quarter of 2020 · Net sales amounted to SEK 23,476m (29,232). Organic sales declined by 16.6%, due to lower volumes. The development of the coronavirus pandemic impacted market demand significantly in our main markets and also resulted in supply constraints in North America.   · Operating income amounted to SEK -62m (1,219), corresponding to a margin of -0.3% (4.2). · Comprehensive cost measures executed to mitigate the effects from the pandemic on earnings.

Lagercrantz Interim Report 2020/21 Q1

1 April – 30 June 2020 · Net revenue decreased by almost 4 percent to MSEK 977 (1,015). The market situation was dominated by uncertainty, primarily connected to the Covid-19 pandemic. · Operating profit (EBITA) amounted to MSEK 124 (130), equivalent to an operating margin of 12.7 percent (12.8). · Profit after financial items amounted to MSEK 93 (105). · Profit after taxes amounted to MSEK 70 (82). Earnings per share before and after dilution amounted to SEK 5.22 for the moving 12-month period (SEK 5.39 for the 2019/20 financial year). · Cash flow from operating activities

Quarterly Report Q2 2020

An extraordinary quarter Second quarter · Net sales decreased by 15% to SEK 19,953 M (23,544), with organic growth of –18% (3) and acquired net growth of 3% (4) · All five divisions reported significant declines in organic growth due to COVID-19. Entrance Systems, reporting organic growth of –8%, was the division least impacted · Three acquisitions with expected combined annual sales of around SEK 200 M were signed · To meet a regulatory precondition by the EU Commission for ASSA ABLOY to acquire agta record, agreements for the sale of certain agta record and ASSA ABLOY

Interim report January - June 2020

A quarter characterized by Covid-19. Despite this, adjusted EBITA was positive as a result of the rapid realignment of operations but also through structural improvement measures through the Lift Up Program. Handicare’s financial position remains strong.Second quarter 2020 · Revenue amounted to MEUR 39.0 (62.9). · Organic growth was -31.6%. · The gross margin was 40.1% (41.2). · Adjusted EBITA amounted to MEUR 0.9 (5.3), corresponding to a margin of 2.4% (8.5). · EBIT was MEUR -8.7 (3.8), including Other specified items of MEUR 8 relating to the Lift Up Program. · Net

Interim report January-June 2020

Quarter 2, 2020 · Incoming orders amounted to SEK 740m (1,044), equivalent to a currency-neutral decrease of 27.7 percent compared with the same period last year. · Net sales amounted to SEK 928m (1,096), equivalent to a currency-neutral decrease of of 14.0 percent compared with the same period last year. · Operating profit, including restructuring costs, was SEK -2.3m (84.5), giving an operating margin of -0.2 percent (7.7). · Adjusted operating profit was SEK 73.0m (84.9), giving an adjusted operating margin of 7.9 percent (7.7). · Net profit was SEK -10.4m (54.4). ·

Outokumpu – Publishing of the half-year financial report on August 7, 2020

Outokumpu OyjPress releaseJuly 17, 2020 at 9.00 am EESTOutokumpu – Publishing of the half-year financial report on August 7, 2020 Outokumpu publishes its half-year financial report, January-June 2020, on August 7, 2020 at approximately 9.00 am EEST. At the same day at 3.00 pm EEST, Outokumpu arranges a conference call and webcast to analysts and investors, hosted in English by CEO Heikki Malinen and CFO Pia Aaltonen-Forsell. Please follow the event online at https://edge.media-server.com/mmc/p/bqs6qww6. To participate in the call, please dial in 15 minutes before the event:

Peab Half-year report: Finalized acquisition reinforces our Nordic position

Peab Half-year report January – June 2020”Peab has weathered the consequences of the corona pandemic relatively well so far. Our business model with four collaborating business areas gives us stability even in uncertain times. The acquisition of paving and mineral aggregates operations reinforces our business model and Nordic position,” says Jesper Göransson, CEO and President of Peab. Summary according to segment reporting: April – June 2020 · Acquisition of paving and mineral aggregates operations from YIT finalized on April 1, 2020 · Net sales SEK 15,518 million (14,527),

There are no items matching the current filter
There are no more items matching the current filter
Back to top